Skip to content
Screener

SAB Biotherapeutics SABS Q4 2025 Annual earnings

Reported March 9, 2026 · After market close

EPS-$0.46Miss by $0.30
Revenue estimate$100.0K
EPS estimate-$0.16

Next report

Nov 13, 2026 (in 2 months)
Revenue estimate$125.0K
EPS estimate-$0.27

FAQ

When did SAB Biotherapeutics report Q4 2025 earnings?
SAB Biotherapeutics (SABS) reported Q4 2025 earnings on March 9, 2026 after market close.
What were SAB Biotherapeutics's Q4 2025 revenue and EPS?
SAB Biotherapeutics reported eps of $-0.46 for Q4 2025.
Did SAB Biotherapeutics beat estimates in Q4 2025?
EPS missed the consensus estimate of $-0.16 by $0.30.
How did SAB Biotherapeutics's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 62.6% from $-1.23.
Where can I find SAB Biotherapeutics's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-099376) and the 10-K periodic report (0001833214-26-000003) directly on SEC EDGAR. The filing index links above go to sec.gov.